RemeGen

Rongchang Biopharmaceuticals (Yantai) Co., Ltd. was co-founded in 2008 by Yantai Rongchang Pharmaceuticals Co., Ltd., led by Mr. Weidong Wang, and Dr. Jianmin Fang, a scientist returning from the United States. Headquartered in Yantai City, Shandong Province, China, Rongchang Biopharmaceuticals has research facilities and offices in both China and the United States. Rongchang Biopharmaceuticals is committed to the discovery, development, manufacturing, and commercialization of first-in-class and best-in-class biopharmaceuticals, creating a portfolio of biologics with significant clinical value targeting major disease areas such as autoimmune diseases, oncology, and ophthalmology. Our mission is to discover, develop, manufacture, and commercialize first-in-class and best-in-class biopharmaceuticals for major disease areas such as autoimmune diseases, oncology, and ophthalmology, creating clinical value and addressing unmet global clinical needs to maximize corporate value. Our vision is to become a leading biopharmaceutical company in China and a world-class biopharmaceutical enterprise internationally.